Janz Christine, Wiesmüller Lisa
Universitätsfrauenklinik und Poliklinik, Prittwitzstrasse 43, D-89075 Ulm, Germany.
Oncogene. 2002 Aug 29;21(38):5929-33. doi: 10.1038/sj.onc.1205757.
In mammalian cells homologous recombination is stimulated, when the replication fork stalls at DNA breaks or unrepaired lesions. The tumor suppressor p53 downregulates homologous recombination independently of its transcriptional transactivation function and has been linked to enzymes of DNA recombination and replication. To study recombination with respect to replication, we utilized a SV40 virus based assay, to follow the synchronous events after primate cell infection. gamma-ray treatment at different times after viral entry unveiled an increase of interchromosomal exchange frequencies, when the damage was introduced during DNA synthesis. Elevated recombination frequencies were fully suppressed by p53. With respect to the downregulation of spontaneous recombination, we noticed a requirement for active p53 molecules, when replication started. After a transient treatment with replication inhibitors, we observed inhibition of the drug induced recombination by p53, particularly for the elongation inhibitor aphidicolin. Consequently, we propose that p53 is a surveillance factor of homologous recombination at replication forks, when they stall as a consequence of endogenous or of exogenously introduced damage.
在哺乳动物细胞中,当复制叉在DNA断裂或未修复的损伤处停滞时,同源重组会被刺激。肿瘤抑制因子p53独立于其转录反式激活功能下调同源重组,并且已与DNA重组和复制的酶相关联。为了研究与复制相关的重组,我们利用基于SV40病毒的检测方法,来追踪灵长类细胞感染后的同步事件。病毒进入后不同时间进行的γ射线处理揭示,当在DNA合成过程中引入损伤时,染色体间交换频率会增加。p53完全抑制了升高的重组频率。关于自发重组的下调,我们注意到当复制开始时,需要有活性的p53分子。在用复制抑制剂进行短暂处理后,我们观察到p53对药物诱导的重组有抑制作用,特别是对于延伸抑制剂阿非科林而言。因此,我们提出,当复制叉由于内源性或外源性引入的损伤而停滞时,p53是复制叉处同源重组的一个监测因子。